TORONTO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (NEO: MEDV; OTC: MEDVF; FRA: 4NC) is pleased to announce that it will be hosting a corporate update presentation with analysts and investors via live webinar on March 8, 2023 at 1pm EST. Participants can register to attend at the following web address:
Registration link:
Specifically, the webinar will feature Medivolve's Chief Executive Officer, David Preiner, to discuss updates on the Company's business developments.
About Medivolve, Inc.
Medivolve, Inc. (NEO: MEDV; OTC: MEDVF; FRA: 4NC) is a healthcare technology company that seeks to reinvent the US healthcare system by leveraging a bespoke telehealth platform, a clinical diagnostic network, and a data-driven AI framework to improve patient care.
The Company was born out of the healthcare crisis; to rethink, relearn and ultimately, reimagine a better way for the healthcare system to operate. Our network of retail collection sites play an important role in recovery by giving Americans access to fast, accurate, and inexpensive clinical services when and where they need it. These centers will also play a pivotal role in diagnostic testing, vaccinations, and other point-of-care services. We are building disruptive technologies to make it easier and faster to identify, treat, and prevent medical issues. In doing so, we are working to give patients a holistic and empowered view of their personal health.
Our long-term mission is to address systemic issues in the nation's fragmented, overly complex, and expensive healthcare system. Medivolve's next phase of growth is about pivoting the model and putting the pieces together to build a profitable health-tech company. We are developing a singular, streamlined technology network to provide data-driven physician consultations, clinical diagnostics, and prescription services. Our team is united by a powerful, singular purpose: harnessing the transformative power of technology to create healthier lives.
Underpinned by a bespoke, AI-driven platform, we're developing a system that constantly gets smarter, takes the guesswork out of diagnostics, and flags critical health issues to help physicians, delivering a high level of personalization for each patient.
For investing inquiries, please contact: David Preiner, CEO, info@medivolve.ca, 702-990-3737.
Cautionary Note Regarding Forward-looking Information
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the Company's future plans. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information, including but not limited to: general business, economic, competitive, political and social uncertainties; accidents, labour disputes and shortages and other risks of the healthcare industry. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
多倫多,2023年2月27日(環球通訊社)-Medivolve Inc.Medivolve“或”公司(NEO:MEDV;OTC:MEDVF;FRA:4NC)高興地宣佈,它將在2023年3月8日美國東部時間下午1點通過現場網路研討會與分析師和投資者舉辦企業最新演示文稿。與會者可以通過以下網址註冊參加:
註冊鏈接:
具體地說,Medivolve首席執行官David·普雷納將在網路研討會上討論公司業務發展的最新情況。
關於Medivolve公司
Medivolve,Inc.(NEO:MEDV;OTC:MEDVF;FRA:4NC)是一家醫療技術公司,尋求通過利用定製的遠端醫療平臺、臨床診斷網路和數據驅動的人工智慧框架來改善患者護理,從而重塑美國醫療體系。
該公司誕生於醫療保健危機;重新思考、重新學習,並最終重新想像醫療保健系統運行的更好方式。我們的零售收集網站網路在康復過程中發揮著重要作用,使美國人能夠隨時隨地獲得快速、準確和廉價的臨床服務。這些中心還將在診斷檢測、疫苗接種和其他醫療保健服務方面發揮關鍵作用。我們正在建設顛覆性技術,使識別、治療和預防醫療問題變得更容易、更快。在這樣做的過程中,我們正在努力讓患者對他們的個人健康有一個全面和授權的看法。
我們的長期使命是解決國家支離破碎、過於複雜和昂貴的醫療體系中的系統性問題。Medivolve的下一階段增長是圍繞著這種模式,並將其整合在一起,打造一家盈利的健康科技公司。我們正在開發一個獨特的、精簡的技術網路,以提供數據驅動的醫生諮詢、臨床診斷和處方服務。我們的團隊團結在一個強大的、唯一的目標上:利用技術的變革性力量創造更健康的生活。
在一個定製的、人工智慧驅動的平臺的支持下,我們正在開發一個不斷變得更智慧的系統,使診斷工作不再是猜測,並標記關鍵的健康問題以幫助醫生,為每個患者提供高水平的個性化。
如有投資查詢,請聯繫:首席執行官David·普雷納電子郵件:info@medivolve.ca
關於前瞻性資訊的注意事項
本新聞稿包含適用於加拿大證券法的“前瞻性資訊”。前瞻性資訊包括但不限於與公司未來計劃有關的陳述。一般而言,前瞻性資訊可通過使用“計劃”、“預期”或“不預期”、“預期”、“預算”、“預定”、“估計”、“預測”、“打算”、“預期”或“不預期”或“相信”等前瞻性術語或此類詞語和短語的變體來確定,或說明某些行動、事件或結果“可能”、“可能”、“將”、“可能”或“將會採取”、“發生”或“將實現”。前瞻性資訊受已知和未知風險、不確定性和其他因素的影響,這些風險、不確定性和其他因素可能導致公司的實際結果、活動水準、業績或成就(視情況而定)與此類前瞻性資訊明示或暗示的內容大不相同,包括但不限於:一般商業、經濟、競爭、政治和社會不確定性;事故、勞資糾紛和短缺以及醫療保健行業的其他風險。儘管公司試圖確定可能導致實際結果與前瞻性資訊中包含的結果大不相同的重要因素,但可能還有其他因素導致結果與預期、估計或預期的不同。不能保證這些資訊將被證明是準確的,因為實際結果和未來事件可能與此類聲明中預期的大不相同。因此,讀者不應過分依賴前瞻性資訊。除非依照適用的證券法,否則公司不承諾更新任何前瞻性資訊。